Boston Scientific Corporation
BSX | NYSE
$44.12
+$2.14 (+5.10%)
Nov 2, 2026, 12:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 2.05B | 414M | 865M | 928M | 1.93B | 1.73B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 842M | 555M | 413M | 407M | 412M | 918M |
Other Long-Term Assets | 559M | 749M | 680M | 707M | 563M | 545M |
Receivables | 2.93B | 2.56B | 2.23B | 1.97B | 1.78B | 1.53B |
Inventory | 2.94B | 2.81B | 2.48B | 1.87B | 1.61B | 1.35B |
Other Current Assets | 580M | 831M | 622M | 731M | 799M | 1.88B |
Total Current Assets | 8.79B | 6.92B | 6.51B | 5.76B | 6.32B | 6.69B |
Property-Plant & Equipment | 4.5B | 3.74B | 3.3B | 2.83B | 2.69B | 2.54B |
Goodwill & Intangibles | 25.3B | 23.77B | 20.39B | 18.82B | 18.11B | 15.87B |
Total Long-Term Assets | 34.88B | 32.48B | 28.62B | 26.71B | 25.91B | 24.08B |
Total Assets | 43.67B | 39.4B | 35.14B | 32.47B | 32.23B | 30.78B |
Account Payables | 1.14B | 960M | 942M | 862M | 794M | 513M |
Deferred Revenue | 313M | 306M | 266M | 220M | 208M | 138M |
Short-Term Debt | 389M | 1.78B | 531M | 20M | 261M | 13M |
Other Current Liabilities | 2.17B | 491M | 1.92B | 1.64B | 629M | 1.17B |
Total Current Liabilities | 5.44B | 6.4B | 4.93B | 3.8B | 4.27B | 3.68B |
Long-Term Debt | 11.46B | 8.84B | 8.57B | 8.91B | 8.8B | 9.12B |
Other Long-Term Liabilities | 1.14B | 1.14B | 1.27B | 1.4B | 1.55B | 1.66B |
Total Long-Term Liabilities | 13.76B | 10.99B | 10.67B | 11.09B | 11.33B | 11.77B |
Total Liabilities | 19.2B | 17.39B | 15.61B | 14.9B | 15.61B | 15.45B |
Total Debt | 12.42B | 11.15B | 9.49B | 9.28B | 9.45B | 9.54B |
Book Value | 24.47B | 22B | 19.53B | 17.57B | 16.62B | 15.33B |
Book Value Per Share | 16.37 | 14.81 | 13.34 | 12.21 | 11.59 | 10.82 |
Common Stock | 17M | 17M | 17M | 17M | 17M | 17M |
Retained Earnings | 5.57B | 2.67B | 819M | -750M | -1.39B | -2.38B |
Comprehensive Income | -610M | 275M | 49M | 269M | 263M | 207M |
Shareholders Equity | 24.23B | 21.77B | 19.28B | 17.57B | 16.62B | 15.33B |
Total Investments | 842M | 555M | 413M | 407M | 412M | 918M |
Add to Watchlist
Select watchlists to add or remove BSX